From: Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer
Cut off | Sensitivity | Specificity | AUC | 95% CI | P-value | |
---|---|---|---|---|---|---|
C vs. AG | miR-101-3p < 0.8765 | 80.33% | 80.00% | 0.8493 | 0.771–0.928 | < 0.0001 |
PG I < 71.56 (μg/l) | 77.05% | 66.00% | 0.7187 | 0.621–0.816 | < 0.0001 | |
PG I/II ratio < 5.6 | 60.66% | 82.00% | 0.7549 | 0.666–0.844 | < 0.0001 | |
CEA > 2.52 (ng/ml) | 41.62% | 86.00% | 0.6289 | 0.526–0.732 | 0.0198 | |
C vs. GC | miR-101-3p < 0.759 | 72.09% | 86.49% | 0.8749 | 0.829–0.921 | < 0.0001 |
PG I < 59.98 (μg/l) | 59.3% | 83.78% | 0.7702 | 0.704–0.836 | < 0.0001 | |
PG I/II ratio < 4.22 | 56.98% | 87.39% | 0.7697 | 0.704–0.835 | < 0.0001 | |
CEA > 2.875 (ng/ml) | 75.58% | 81.98% | 0.8235 | 0.760–0.887 | < 0.0001 | |
AG vs. GC | miR-101-3p < 0.756 | 68.60% | 77.05% | 0.7710 | 0.697–0.845 | < 0.0001 |
PG I < 58.22 (μg/l) | 51.16% | 86.89% | 0.7130 | 0.631–0.795 | < 0.0001 | |
PG I/II ratio < 4.01 | 52.33% | 83.61% | 0.6760 | 0.587–0.764 | < 0.0001 | |
CEA > 2.875 (ng/ml) | 75.58% | 75.41% | 0.7850 | 0.710–0.860 | < 0.0001 |